Skip to main content
RCAT
NASDAQ Technology

Shareholders Reject Four Director Nominees and Executive Compensation Plan

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$9.075
Mkt Cap
$1.381B
52W Low
$5.77
52W High
$18.78
Market data snapshot near publication time

Summary

Red Cat Holdings shareholders rejected four director nominees and voted against the executive compensation plan at the annual meeting, indicating widespread dissatisfaction with the company's governance and leadership.


Key Events

  • Four Director Nominees Not Elected

    Four out of five proposed directors (Joseph Freedman, Nicholas Liuzza Jr., Christopher R. Moe, and General (R) Paul E. Funk II) failed to receive sufficient votes for re-election at the Annual Meeting. Only Jeffrey M. Thompson was re-elected.

  • Executive Compensation Plan Rejected

    Shareholders cast a non-binding advisory vote against the compensation of the Named Executive Officers, indicating significant dissatisfaction with executive pay practices.

  • Auditor Appointment Ratified

    KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.


Analysis

The failure to re-elect four out of five director nominees, coupled with the rejection of the executive compensation plan, signals a significant loss of confidence by shareholders in the company's current leadership and governance. This outcome could lead to substantial changes in the board's composition and strategic direction, especially following recent dilutive offerings and ongoing financial challenges such as increased net loss and operating cash burn.

At the time of this filing, RCAT was trading at $9.08 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $5.77 to $18.78. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RCAT - Latest Insights

RCAT
Jun 25, 2026, 11:41 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $9.08
Real-time Price: $9.34 info
Change: +$0.265 (+3%) info
Market Cap: $1.412B info
RCAT
May 28, 2026, 11:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $13.49
Real-time Price: $9.34 info
Change: -$4.15 (-31%) info
Market Cap: $1.412B info
RCAT
May 20, 2026, 6:35 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.00
Real-time Price: $9.34 info
Change: +$0.340 (+4%) info
Market Cap: $1.412B info
RCAT
May 20, 2026, 6:28 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $8.69
Real-time Price: $9.34 info
Change: +$0.650 (+7%) info
Market Cap: $1.412B info
RCAT
May 18, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.95
Real-time Price: $9.34 info
Change: +$0.395 (+4%) info
Market Cap: $1.412B info
RCAT
May 14, 2026, 5:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.74
Real-time Price: $9.34 info
Change: -$0.400 (-4%) info
Market Cap: $1.412B info
RCAT
May 14, 2026, 6:28 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $9.65
Real-time Price: $9.34 info
Change: -$0.310 (-3%) info
Market Cap: $1.412B info
RCAT
May 13, 2026, 9:02 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $9.60
Real-time Price: $9.34 info
Change: -$0.260 (-3%) info
Market Cap: $1.412B info
RCAT
May 12, 2026, 11:18 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $9.90
Real-time Price: $9.34 info
Change: -$0.555 (-6%) info
Market Cap: $1.412B info
RCAT
May 12, 2026, 5:15 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $9.94
Real-time Price: $9.34 info
Change: -$0.600 (-6%) info
Market Cap: $1.412B info